Evogene Ltd. (EVGN)

Evogene Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	11.92	20.77	28.98	32.33	46.23	34.75
Short-Term Investments	14.7	10.29	6.38	21.54	2	12.13
Cash & Cash Equivalents	26.61	31.06	35.36	53.87	48.23	46.88
Cash Growth	-7.58%	-12.14%	-34.36%	11.69%	2.89%	-13.94%
Receivables	3.69	3.33	1.83	2.93	3.59	2.15
Inventory	0.72	0.08	0.57	0.09	0	0
Total Current Assets	31.02	34.47	37.75	56.89	51.82	49.03
Property, Plant & Equipment	2.68	3.44	4.07	4.18	3.94	5.25
Long-Term Investments	0.13	0	0	0	0.01	0.01
Goodwill and Intangibles	12.92	13.17	14.14	15.21	16.14	17.07
Other Long-Term Assets	0.03	0.03	0.17	0.03	0	0
Total Long-Term Assets	15.76	16.63	18.38	19.41	20.09	22.34
Total Assets	46.78	51.1	56.13	76.3	71.92	71.36
Accounts Payable	2.01	2.8	2.65	2.98	2.1	2.35
Deferred Revenue	0.82	0.76	0.02	0.18	0.05	0.39
Current Debt	0.72	0.85	0.88	0.97	0.78	0.9
Other Current Liabilities	2.59	2.53	2.07	2.75	6.75	2.12
Total Current Liabilities	6.13	6.94	5.63	6.88	9.68	5.75
Long-Term Debt	10.63	10.65	11.05	1.7	1.66	2.08
Other Long-Term Liabilities	4.64	4.82	4.67	4.31	3.69	3.33
Total Long-Term Liabilities	15.27	15.47	15.71	6	5.36	5.4
Total Liabilities	21.4	22.42	21.34	12.88	15.03	11.15
Total Debt	11.34	11.51	11.93	2.67	2.44	2.97
Debt Growth	-5.08%	-3.55%	346.98%	9.39%	-17.87%	-
Retained Earnings	-261.45	-257.59	-233.71	-207.07	-179.28	-155.9
Shareholders' Equity	8.29	12.05	27.93	53.65	46.05	50.14
Net Cash / Debt	15.27	19.56	23.43	51.2	45.79	43.91
Net Cash / Debt Growth	-9.35%	-16.51%	-54.25%	11.81%	4.29%	-19.39%
Net Cash Per Share	0.30	0.43	0.57	1.27	1.63	1.70
Working Capital	24.89	27.53	32.13	50.01	42.15	43.28
Book Value Per Share	0.16	0.26	0.68	1.33	1.64	1.95

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).